Back to BlackRock, Inc. BlackRock, Inc.

CRVSCRVS
8 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in CORVUS PHARMACEUTICALS INC

Yes. BlackRock holds 7,138,811 shares of CRVS (Corvus Pharmaceuticals), worth $106.7M, as of its Q2 2026 13F filing. It increased the position by 978,389 shares (+15.9%) from Q1 2026. BlackRock has held CRVS in every 13F on record since Q3 2024, 8 quarterly filings.

Current Value

$106.7M

Current Shares

7.1M

Total Value Change

+$103.5M

Total Shares Change

+6.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
7.1M
+15.9%
$106.7M0.0%$14.94
35
2026-Q1
Increased
6.2M
+21.8%
$90.1M0.0%$17.53
36
2025-Q4
Increased
5.1M
+7.3%
$38.9M0.0%$7.49
31
2025-Q3
Increased
4.7M
+11.1%
$34.7M0.0%$7.28
32
2025-Q2
Increased
4.2M
+301.0%
$17M0.0%$3.89
46
2025-Q1
Decreased
1.1M
-1.5%
$3.4M0.0%$3.38
0
2024-Q4
Increased
1.1M
+77.7%
$5.7M0.0%$5.35
41
2024-Q3
First report
603,877
-
$3.2M0.0%$5.28
0

Other major holders of CRVS: STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD CAPITAL MANAGEMENT LLC, Point72 Asset Management, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used